Most update source of PCIP3-0 pdf download is killexams.com

We are all proud of assisting folks to pass the particular PCIP3-0 test in their particular very first tries with our PCIP3-0 practice test plus Exam dumps. The success in the particular past two yrs is already absolutely amazing, because of the happy Payment Card Industry Professional customers which are now in a position to boost their profession in the quick lane. killexams.com will be the number single choice among professionals, especially the particular kinds that are usually looking to rise in the structure levels faster within their re

Exam Code: PCIP3-0 Practice test 2022 by Killexams.com team
PCIP3-0 Payment Card Industry Professional

The qualification test is administered at a Pearson VUE Test Center. You will have 90 minutes to complete 75 multiple-choice questions. No electronic devices may be used during the closed-book exam.

All scheduling/rescheduling is done via Pearson VUEs online scheduling system – you select the test location, date and time most convenient for you.
You will receive an email containing Instructions and a voucher to schedule your test within 2-3 business days of payment processing.
If you choose the Exam-only or instructor-led class option, the test must be completed within a 30 day test window. If you choose the eLearning Course, the test must be completed within a 90 days test window. Exam Results and Next Steps

Pass/Fail results are provided immediately following the conclusion of your exam.
Passing candidates will receive a Certificate of Qualification via email within 2-3 business days.
If a passing score is not achieved, a total of three (3) attempts are permitted (a retake fee will apply).

The Payment Card Industry Professional is an individual, entry-level qualification in payment security information and provides you with the tools to help your organization build a secure payment environment. Becoming a PCIP demonstrates a level of understanding that can provide a strong foundation for a career in the payments security industry. This renewable career qualification is not affected by changes in employment assignments and stays in effect as long as the individual continues to meet requirements. This three-year credential also provides a great foundation for other PCI qualifications.

- Support your organizations or clients ongoing security and compliance efforts through your knowledge of how to apply PCI Standards
- Gain recognition of your professional achievement with this renewable three-year industry credential
- Become part of a PCIP community where knowledge and best practices can be shared
- Launch your career in the payments industry with a competitive advantage
- Listing in a searchable directory on the PCI website
- Earn Continuing Professional Education (CPE) credits

This course outlines the PCI Standards and provides you with the tools to build a secure payments environment and help your organization achieve PCI compliance. Course highlights include:

- Principles of PCI DSS, PA-DSS, PCI PTS, and PCI P2PE Standards
- Understanding of PCI DSS requirements and intent
- Overview of basic payment industry terminology
- Understanding the transaction flow
- Implementing a risk-based prioritized approach
- Appropriate uses of compensating controls
- Working with third-parties and service providers
- How and when to use Self-Assessment Questionnaires (SAQs)
- Recognizing how new technologies affect the PCI (e.g. virtualization, tokenization, mobile, cloud)

Payment Card Industry Professional
PCI-Security Professional learning
Killexams : PCI-Security Professional learning - BingNews https://killexams.com/pass4sure/exam-detail/PCIP3-0 Search results Killexams : PCI-Security Professional learning - BingNews https://killexams.com/pass4sure/exam-detail/PCIP3-0 https://killexams.com/exam_list/PCI-Security Killexams : PCI Pal Named "Data Security Solution Provider of the Year" in 2022 CyberSecurity Breakthrough Awards Program

Prestigious International Awards Program Recognizes Outstanding Information Security Products and Companies

CHARLOTTE, N.C., October 06, 2022--(BUSINESS WIRE)--PCI Pal® (LON: PCIP), a global SaaS secure payments provider, today announced that it has been named winner of the "Data Security Solution Provider of the Year" award in the 6th annual CyberSecurity Breakthrough Awards program conducted by CyberSecurity Breakthrough, a leading independent market intelligence organization that recognizes the top companies, technologies and products in the global information security market today.

PCI Pal provides breakthrough PCI compliance solutions that empower companies to take payments securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss.

PCI Pal prioritizes Customer Experience (CX) without sacrificing payment security and compliance. PCI Pal Digital provides a true omnichannel secure payment solution enabling organizations to take payments across digital engagement channels that include: webchat, Whatsapp, social media, email and SMS.

Additionally, PCI Pal Agent Assist utilizes DTMF masking technology, as well as speech recognition for customers who can’t use their telephone keypad, to provide companies with a secure way of handling payments by phone without bringing their environments in scope of PCI DSS. PCI Pal integrates with the call flow and intercepts any keypad tones or speech from the customer at the point of payment. The agent doesn’t hear or see the card data, and the customer and the agent can still converse throughout the process without the agent or environment accessing the sensitive information, leaving customers comforted and providing them a seamless experience.

"We’re thrilled to accept this accolade from CyberSecurity Breakthrough and to be recognized for a second time. PCI Pal is dedicated to making the payment customer experience great, by prioritizing privacy and security for customers through our omnichannel payment solutions for contact centers," said Jane Goodayle, Chief Marketing Officer, PCI Pal.

The mission of the CyberSecurity Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of information security categories, including Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Email Security and many more. This year’s program attracted more than 4,100 nominations from over 20 different countries throughout the world.

"Due to the uptick in cybercrime, customers have been left uneasy - not knowing who to trust with their information. According to one exact consumer study, over a third of respondents said they vet a company’s security practices before handing over personal information and almost another third felt that disjointed, or unfamiliar payment processes would leave them to refrain from checking out," said James Johnson, managing director, CyberSecurity Breakthrough. "Consumers want to make payments with confidence, and PCI Pal uses an array of proprietary technology solutions that equip them to rapidly support companies who have a remote workforce model overnight. Congratulations on being our choice for 'Data Security Solution Provider of the Year.’"

About PCI Pal
PCI Pal (LON: PCIP) is a leading provider of SaaS solutions that empower companies to take payments securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Using patented technology, its mission is to safeguard reputation and trust by providing customers with secure payment solutions for any business communications environment including voice, chat, social, email, and contact center. PCI Pal is integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers. PCI Pal products can be used by any size organization globally, and it is proud to work with some of the largest and most respected brands in the world. For more information visit www.pcipal.com and https://www.linkedin.com/company/pcipal/.

About CyberSecurity Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the CyberSecurity Breakthrough Awards program is devoted to honoring excellence in information security and cybersecurity technology companies, products and people. The CyberSecurity Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough information security companies and products in categories including Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Web and Email Security, UTM, Firewall and more. For more information visit CyberSecurityBreakthrough.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005234/en/

Contacts

Kelsey Nass, SourceCode Communications
pcipal@sourcecodecomms.com

Thu, 06 Oct 2022 01:02:00 -0500 en-US text/html https://finance.yahoo.com/news/pci-pal-named-data-security-130000976.html
Killexams : Decisions Achieves PCI DSS and SOC2 Type 1 Compliant Recertification

VIRGINIA BEACH, Va., Oct. 5, 2022 /PRNewswire/ -- Today, Decisions announced it had achieved recertification of Payment Card Industry Data Security Standard (PCI DSS) as a Licensed Application. In addition, Decisions was recertified in SOC 2 Type 1 and attained HIPAA (Health Insurance Portability and Accountability Act) compliance standards. 

Decisions is a leading provider of BPM/Workflow/Rule Technology headquartered in Chesapeake, Virginia. (PRNewsfoto/Decisions)

Decisions Achieves PCI DSS and SOC2 Type 1 Compliant Recertification

PCI DSS is a security standard established by the PCI Security Council to ensure cardholder data is protected by all companies that process, store, or transmit credit card information.

While PCI DSS applies to businesses that process payment card data, SOC 2 specifies how personal customer information and data of any kind should be managed to remain secure. These credentials reinforce Decisions' commitment to protecting their customers and prioritizing security.

"Achieving recertification in PCI DSS and SOC 2 with HIPAA standards demonstrates the investments we've made in data protection and assures our customers and partners that sensitive data is being protected," said Heath Oderman, Co-founder and CTO for Decisions. "Data exposure is extremely harmful to businesses and these achievements underline our continuing dedication to privacy and security."

To accomplish these milestones, a dedicated IT team collaborated with auditors over several months. Their collective work has set the foundation for achieving further data security certifications.

About Decisions
With the Decisions no-code automation platform you can fix the customer experience, modernize legacy systems, ensure regulatory compliance, and automate anything in your business. We help people who know what to do, get it done, and change their world.

Cision View original content to obtain multimedia:https://www.prnewswire.com/news-releases/decisions-achieves-pci-dss-and-soc2-type-1-compliant-recertification-301641855.html

SOURCE Decisions

Wed, 05 Oct 2022 08:22:00 -0500 en text/html https://markets.businessinsider.com/news/stocks/decisions-achieves-pci-dss-and-soc2-type-1-compliant-recertification-1031785592
Killexams : Service NSW beefing up PCI compliance with cloud payment service

The NSW Department of Customer Service will soon begin implementation of a cloud-hosted, PCI-DSS compliant phone payment system.

In a recently-published contract notice, Cloudwave is identified as winning the $10 million deal.

The department approached the market last year because its legacy environment needed strengthening “to achieve full PCI DSS [payment card industry data security standard] compliance”.

The organisation wanted a solution that would let call centre agents process payments without customers having to “verbally provide credit details over the phone”.

The other key requirement for PCI DSS compliance was that the phone system mask the dual-tone multi-frequency (DMTF) tones sent by the customer’s phone to execute a transaction. 

Unmasked, the DMTF tones left customers open to interception attacks, Service NSW’s tender states.

Masking the tone “eliminates man-in-the-middle (MitM) attacks and ensures that credit card information is never transmitted to an agent or traverses the internet”, the tender notes.

A Department of Customer Service spokesperson said Cloudwave will provide “Twilio carrier services such as SMS notifications and a PCI-DSS solution to the Virtual Contact Centre (VCC).”

Hosted on the Genesys Cloud platform, the VCC is a NSW government digital asset offered as a service to public sector organisations.

“Twilio Session Initiation Protocol (SIP) as a service allows users to initiate, terminate and modify sessions on a secure network”, the spokesperson added.

“This service replaced traditional SIP channels where a call comes into a contact centre call queue, and will now enable more flexibility to meet the demands of contact centres across the NSW government.

“The VCC currently supports contact centre operations in Service NSW, Better Regulation Division, SIRA, Revenue NSW, icare, Transport for NSW and parts of local government.”

The spokesperson said the PCI-DSS solution integrates with the Department of Customer Service’s customer payment platform, and “strengthens and enhances” phone payment processes “for both customers and DCS”.

The spokesperson added: “The Twilio model incorporates multi-carriers to ensure service availability and resilience in times of peak demands.”

Cloudwave’s contract runs to August 2025.

Tue, 04 Oct 2022 18:44:00 -0500 text/html https://www.itnews.com.au/news/service-nsw-beefing-up-pci-compliance-with-cloud-payment-service-585863
Killexams : PCI Pal Teams Up with Virgin Atlantic to Secure its Global Omnichannel Payments No result found, try new keyword!PCI Pal (LON: PCIP), the global provider of secure payment solutions, has announced that its solution, PCI Pal Digital, has been “selected by Virgin Atlantic to support the airline’s ... Sat, 01 Oct 2022 04:49:00 -0500 en-US text/html https://www.crowdfundinsider.com/2022/10/196699-pci-pal-teams-up-with-virgin-atlantic-to-secure-its-global-omnichannel-payments/ Killexams : PCI Pal Introduces Open Banking Payments for Contact Centers No result found, try new keyword!Pay by Bank from PCI Pal “uses bank-grade security from our technology partner TrueLayer and is seamlessly integrated to PCI Pal’s existing agent-assisted contact center solutions.” ... Thu, 22 Sep 2022 13:29:00 -0500 en-US text/html https://www.crowdfundinsider.com/2022/09/196333-pci-pal-introduces-open-banking-payments-for-contact-centers/ Killexams : Long-term outcomes of PCI, CABG compared for multivessel CAD

For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-eluting stent or coronary artery bypass grafting (CABG), according to a study published online Sept. 19 in Circulation to coincide with the annual Transcatheter Cardiovascular Therapeutics conference, held from Sept. 16 to 19 in Boston.

Jung-Min Ahn, M.D., from the University of Ulsan College of Medicine in Seoul, South Korea, and colleagues conducted a prospective, randomized controlled trial at 27 international heart centers. The trial was designed for 1,776 patients with angiographic multivessel coronary artery disease who were randomly assigned to PCI with everolimus-eluting stent or CABG. The trial was terminated early after inclusion of 880 patients (438 and 442 in the PCI and CABG groups, respectively) due to slow enrollment.

The researchers found that the primary end point—the composite of death from any cause, , or target-vessel revascularization—occurred in 34.5 percent of patients in the PCI group and 30.3 percent of patients in the CABG group during a median follow-up of 11.8 years. The occurrence of a safety composite of death, myocardial infarction, or stroke did not differ significantly between the groups, nor did occurrence of death from any cause. However, spontaneous myocardial infarction and any repeat revascularization occurred significantly more frequently after PCI than CABG (7.1 versus 3.8 percent and 22.6 versus 12.7 percent, respectively).

"The extended follow-up of the BEST trial provides important long-term insights that could aid in decision-making for the optimal revascularization strategy in patients with multivessel ," the authors write.



More information: Jung-Min Ahn et al, Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial, Circulation (2022). DOI: 10.1161/CIRCULATIONAHA.122.062188

Copyright © 2022 HealthDay. All rights reserved.

Citation: Long-term outcomes of PCI, CABG compared for multivessel CAD (2022, October 5) retrieved 17 October 2022 from https://medicalxpress.com/news/2022-10-long-term-outcomes-pci-cabg-multivessel.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Wed, 05 Oct 2022 05:22:00 -0500 en text/html https://medicalxpress.com/news/2022-10-long-term-outcomes-pci-cabg-multivessel.html
Killexams : Real-World Complexities of PCI vs CABG in Left Main Coronary Disease on Display in SCAAR Analysis

Randomized comparisons of percutaneous coronary intervention (PCI) and coronary bypass surgery (CABG) for left-main coronary disease, including those that have sparked very public debate, naturally enrolled patients suitable for either procedure. But that takes a toll on their relevance to clinical practice, where patients are not so narrowly defined.

It also highlights the role of patient registries in guiding real-world decisions, despite their own limitations. So, when researchers from a respected national patient registry recently reported a significant 59% jump in all-cause mortality for PCI compared with CABG in left-main disease, it probably more reflected the complexities of the overwhelming majority of patients who are treated outside of clinical trials than relative efficacy of either treatment.

The group's analysis, based on more than 10,000 patients in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) who underwent revascularization for left-main disease over the last 7 years, also identified a subgroup for which PCI appeared better for survival.

"The benefit of CABG was highest in younger patients with longer life expectancy, and PCI was associated with lower mortality in patients over [age] 80 years," who made up about 30% of the cohort, said Elmir Omerovic, MD, PhD, Sahlgrenska University Hospital, Gothenburg, Sweden, when presenting the analysis September 19 at Transcatheter Cardiovascular Therapeutics (TCT) 2022, held in Boston.

The SCAAR investigators had knowingly thrown themselves into an ongoing and sometimes fiery debate on the relative merits of PCI and CABG for left-main disease and, more dramatically, on alleged improprieties in how one of the issue's key trials, EXCEL, was analyzed and reported.

There were no surgeons among the moderators or panelists attending Omerovic's presentation.

He acknowledged the analysis was almost, by definition, purely observational and had potential for selection bias and residual confounding. Although it controlled for some differences between the 5391 patients treated with PCI and the 4863 who underwent CABG, the groups had sharp baseline differences.

Those getting PCI in some ways were sicker; they had significantly more renal dysfunction, higher Killip class, and greater history of prior myocardial infarction, PCI, and CABG. But they were less likely to have multivessel disease. Still, the study's multivariate analysis adjusted for such differences.

The hazard ratio (HR) for all-cause mortality after PCI compared with CABG, Omerovic reported, was 1.59 (95% CI, 1.11 - 2.27, P = .011) over about 8 years of follow-up. Significant differences were observed by age, with an interaction P = .015. The HRs were:

  • 1.74 (95% CI, 1.39 - 2.18) among patients younger than 80 

  • 0.78 (95% CI, 0.64 - 0.95) for those aged 80 and older

"Real-world studies have a role, and randomized, tightly controlled clinical trials have a role," Eric A. Cohen, MD, Sunnybrook Health Sciences Center, Toronto, Canada, observed for theheart.org | Medscape Cardiology. The SCAAR analysis should carry some weight in the left-main revascularization debate, he said, but it's currently hard to say how much.

For many in the field, "all things being equal, surgery may be the preferred default for people with highly complex disease, with left-main disease, certainly those with diabetes. But there are many things that will alter that default strategy," said Cohen, an interventional cardiologist not connected with the SCAAR registry.

For example, "In a real-world, all-comers registry, one thing that's not controlled for is the goal of therapy. You could have an elderly patient with comorbidities and severe multivessel disease and severe symptoms," in which case PCI might well be preferred. "The goal may not be to treat all the disease and extend life, [rather] it may be to get short-term symptom relief."

In contrast, Cohen said, patients in randomized trials "are much more homogeneous coming into it, and the goal of therapy is presumably both symptoms and prognosis."

Because of its immense potential for selection bias and other limitations associated with observational data, the SCAAR analysis probably won't greatly influence the ongoing debate over left-main revascularization, Ori Ben-Yehuda, MD, Cardiovascular Research Foundation, New York City, also not with SCAAR, told theheart.org | Medscape Cardiology.

"Registry data is hypothesis-generating," noted Ben-Yehuda, an interventional cardiologist. "I don't think it can or should inform our decisions to a large extent, except for some things that also make biological sense. For example, the higher risk identified in the SCAAR registry for CABG in those greater than age 80, I think is something we need to look at." However, "I would advocate for registry-based randomized trials, especially where there is equipoise."

That CABG emerged as more lifesaving in the registry "I don't actually think is controversial at all," said Ajay J. Kirtane, MD, SM, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York City, an interventional cardiologist also not connected with SCAAR.

The results aren't surprising "given what we know about observational data," and differences between the CABG cohort and "patients who were selected for PCI, not randomized to PCI," Kirtane said as a panelist following Omerovic's presentation.

"We know that these patients are inherently going to be different than the patients who are selected for surgery," he said. "That's the reason why we do randomized trials. And so a priori going into an analysis like this, if you had found something different — such as PCI associated with better outcomes — that would be surprising to me."

Omerovic and Ben-Yehuda report no relevant financial relationships. Cohen discloses receiving grant support from and holding research contracts with Abbott Vascular; and receiving fees for consulting, honoraria, or serving on a speaker's bureau for Abbott Vascular, Medtronic, and Baylis.

Kirtane reports receiving institutional funding from Medtronic, Boston Scientific, Abbott Vascular, Amgen, CSI, Philips, ReCor Medical, Neurotronic, Biotronik, Chiesi, Bolt Medical, Magenta Medical, Canon, SoniVie, Shockwave Medical, and Merck; consulting for IMDS; and receiving travel and meal expenses from Medtronic, Boston Scientific, Abbott Vascular, CSI, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. 

Transcatheter Cardiovascular Therapeutics 2022. Late-Breaking Clinical Science in Coronary Artery Disease: Session V, in Collaboration with The Lancet. Presented September 19, 2022.

Follow Steve Stiles on Twitter: @SteveStiles2. For more from theheart.org | Medscape Cardiology, follow us on Twitter and Facebook.

Wed, 21 Sep 2022 12:00:00 -0500 Steve Stiles en text/html https://www.medscape.com/viewarticle/981257
Killexams : PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term

BOSTON -- For multivessel coronary artery disease, percutaneous coronary intervention (PCI) pulled even, statistically speaking, with surgery for outcomes after a median of nearly 12 years of follow-up in the Korean BEST trial, but it appeared unlikely to change minds on relative merits of the two approaches.

The primary composite endpoint of death from any cause, myocardial infarction, or target-vessel revascularization occurred in 34.5% of PCI-treated patients and 30.3% of those who received coronary artery bypass grafting (CABG; HR 1.18, 95% CI 0.88-1.56).

There were also no significant differences in a safety composite of death, myocardial infarction, or stroke, or all-cause mortality alone, at a median 11.8 years of follow-up, reported Jung-Min Ahn, MD, of Asan Medical Center in Seoul, during the Transcatheter Cardiovascular Therapeutics (TCT) meeting hosted by the Cardiovascular Research Foundation (CRF). The results were simultaneously published in Circulation.

"This extended follow-up study was important for long-term insights for how to decide revascularization strategy in patients with multivessel disease," Ahn said at a press conference for the late-breaking clinical trial session.

"Still, bypass surgery is the gold standard for the treatment of multivessel disease patients," he added. "Some patients want to avoid major bypass surgery. If they have suitable anatomy for PCI, then I think based on this trial PCI would be the reasonable alternative to the bypass surgery if PCI was performed with current generation drug-eluting stents under image guidance."

That message was seconded by TCT press conference panelist Carlo Di Mario, MD, PhD, of Careggi University Hospital in Florence, Italy. "With the exception of diabetes and extremely diffuse disease, there are no signals in favor of CABG versus PCI for mortality and stroke, the two truly hard endpoints. There is an advantage in terms of less target-lesion revascularization -- in my view a small price to pay."

In the trial, secondary endpoints favored CABG with a relative 86% lower risk of spontaneous myocardial infarction (3.8% vs 7.1%, P=0.03) and a 92% lower likelihood of any repeat revascularization (12.7% vs 22.6%, P<0.001).

Prior multivessel disease studies have shown better outcomes with CABG over PCI in the short term (at 1 year with fractional flow reserve-guided use of current-generation stents in the FAME 3 trial) and through 5 years (in a diabetes population with first-generation drug-eluting stents in FREEDOM) and 10 years (with first-generation drug-eluting stents in SYNTAX for three-vessel disease).

Main results from the BEST trial, which randomized patients to second-generation everolimus-eluting stents versus CABG, showed higher risk of the primary endpoint with PCI at 2 years (11.0% vs 7.9%, P=0.32 for noninferiority).

With regard to the long-term results, press conference panelist Eric A. Cohen, MD, of the Schulich Heart Program at Sunnybrook Health Sciences Centre in Toronto, noted, "I don't think statistically there's anything here clearly inconsistent with other findings. The fact that at 10 years these findings look slightly more favorable or less detrimental for PCI might reflect the higher use of intravascular imaging, the single stent platform, and completeness of revascularization being relatively higher [compared with prior trials]."

The extended clinical follow-up portion of the trial included data on 865 patients of the originally enrolled 880 (out of a planned 1,776 due to slow enrollment) who were followed for a minimum of 8 years and up to 13.7 years. Complete revascularization had been achieved in 50.9% of PCI patients and 71.5% of CABG patients.

Completeness of revascularization "is an issue that favors bypass surgery," noted Di Mario. "I agree 50% doesn't look so high, despite being higher than other previous CABG versus PCI trials."

Ahn said that a subgroup analysis pointed to no interaction between complete and incomplete revascularization for the primary endpoint. A landmark analysis at 5 years of follow-up showed similar findings to the overall analysis for the primary and safety endpoints as well.

But the picture might be different in a trial that was performed now, Di Mario suggested. "Now that CTO [chronic total occlusion] techniques have improved, probably this percentage [complete revascularization] is likely to reach the surgical level."

However, what Ahn called an "interesting hypothesis-generating analysis" suggested that intravascular ultrasound (IVUS) guidance, used in about 72% of PCI cases in the trial, had a substantial impact on the outcomes. With IVUS, the primary endpoint rate was 22.8%, on par with CABG's 24.0%, whereas it was 44.3% for PCI without IVUS. All-cause mortality occurred in 11.6% of IVUS-guided PCI cases, similar to the 15.7% with CABG, but 24.5% with PCI sans IVUS.

Noting that the repeat revascularization difference between strategies was "essentially nullified" with IVUS, press conference moderator Gary Mintz, MD, of the CRF and MedStar Cardiovascular Research Network in Washington, D.C., said, "It's sort of time to compare modern PCI versus modern surgery, rather than just letting people do whatever they want."

Ori Ben-Yehuda, MD, of the CRF Clinical Trials Center in New York City, another press conference moderator, also noted that "modern PCI" often does not mean IVUS guidance in real-world practice. "My take-away is that individual patient decision making, and particularly having the patient as an advocate for themselves, is very important here, where outcomes are very similar over time."

Disclosures

BEST was funded by the Cardiovascular Research Foundation and Abbott Vascular.

Ahn, Di Mario, Cohen, and Ben-Yehuda disclosed no relevant relationships with industry.

Mintz disclosed relationships with Boston Scientific, Medtronic, and Abiomed.

Mon, 19 Sep 2022 05:29:00 -0500 en text/html https://www.medpagetoday.com/meetingcoverage/tct/100791
Killexams : PCI HQ sold to Milestone Development of Western New York No result found, try new keyword!The investment group that bought a former West Side firehouse earlier this year has acquired the former PCI headquarters building in downtown Buffalo. 703 Washington Street LLC, a group affiliated ... Fri, 23 Sep 2022 07:45:00 -0500 text/html https://www.bizjournals.com/buffalo/news/2022/09/23/pci-sells-downtown-hq-for-875-000.html Killexams : PCI Pal Named “Data Security Solution Provider of the Year” in 2022 CyberSecurity Breakthrough Awards Program

The MarketWatch News Department was not involved in the creation of this content.

CHARLOTTE, N.C., (BUSINESS WIRE) -- PCI Pal®(LON: PCIP), a global SaaS secure payments provider, today announced that it has been named winner of the “Data Security Solution Provider of the Year” award in the 6th annual CyberSecurity Breakthrough Awards program conducted by CyberSecurity Breakthrough, a leading independent market intelligence organization that recognizes the top companies, technologies and products in the global information security market today.

PCI Pal provides breakthrough PCI compliance solutions that empower companies to take payments securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss.

PCI Pal prioritizes Customer Experience (CX) without sacrificing payment security and compliance. PCI Pal Digital provides a true omnichannel secure payment solution enabling organizations to take payments across digital engagement channels that include: webchat, Whatsapp, social media, email and SMS.

Additionally, PCI Pal Agent Assist utilizes DTMF masking technology, as well as speech recognition for customers who can’t use their telephone keypad, to provide companies with a secure way of handling payments by phone without bringing their environments in scope of PCI DSS. PCI Pal integrates with the call flow and intercepts any keypad tones or speech from the customer at the point of payment. The agent doesn’t hear or see the card data, and the customer and the agent can still converse throughout the process without the agent or environment accessing the sensitive information, leaving customers comforted and providing them a seamless experience.

“We’re thrilled to accept this accolade from CyberSecurity Breakthrough and to be recognized for a second time. PCI Pal is dedicated to making the payment customer experience great, by prioritizing privacy and security for customers through our omnichannel payment solutions for contact centers,” said Jane Goodayle, Chief Marketing Officer, PCI Pal.

The mission of the CyberSecurity Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of information security categories, including Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Email Security and many more. This year’s program attracted more than 4,100 nominations from over 20 different countries throughout the world.

“Due to the uptick in cybercrime, customers have been left uneasy - not knowing who to trust with their information. According to one exact consumer study, over a third of respondents said they vet a company’s security practices before handing over personal information and almost another third felt that disjointed, or unfamiliar payment processes would leave them to refrain from checking out,” said James Johnson, managing director, CyberSecurity Breakthrough. “Consumers want to make payments with confidence, and PCI Pal uses an array of proprietary technology solutions that equip them to rapidly support companies who have a remote workforce model overnight. Congratulations on being our choice for 'Data Security Solution Provider of the Year.’”

About PCI Pal
PCI Pal (LON: PCIP) is a leading provider of SaaS solutions that empower companies to take payments securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Using patented technology, its mission is to safeguard reputation and trust by providing customers with secure payment solutions for any business communications environment including voice, chat, social, email, and contact center. PCI Pal is integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers. PCI Pal products can be used by any size organization globally, and it is proud to work with some of the largest and most respected brands in the world. For more information visit www.pcipal.com and https://www.linkedin.com/company/pcipal/.

About CyberSecurity Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the CyberSecurity Breakthrough Awards program is devoted to honoring excellence in information security and cybersecurity technology companies, products and people. The CyberSecurity Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough information security companies and products in categories including Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Web and Email Security, UTM, Firewall and more. For more information visit CyberSecurityBreakthrough.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005234/en/

SOURCE: PCI Pal

Kelsey Nass, SourceCode Communications
pcipal@sourcecodecomms.com

COMTEX_416038463/2456/2022-10-06T09:00:27

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

The MarketWatch News Department was not involved in the creation of this content.

Thu, 06 Oct 2022 01:00:00 -0500 en-US text/html https://www.marketwatch.com/press-release/pci-pal-named-data-security-solution-provider-of-the-year-in-2022-cybersecurity-breakthrough-awards-program-2022-10-06
PCIP3-0 exam dump and training guide direct download
Training Exams List